Any "China concern" is $quashed
Our Loveable Pharma CEOs are All In
I've been a bit concerned as China slips into the passing lane on many American leadership positions. No such concern, apparently, by Big Pharma.
Endpoint News is a Pharma newsletter operation, and their vision is clear: "Looks like a chance for big bucks to me," pretty much sums it up. No concern, no fear for loss of intellectual property, just more chances for giant profits.
SOooo, does Big Pharma see this Chinese incursion as a threat or an opportunity?
Is that the Pharmaceutical industry sees its central drive as economic. "Invent great medicines" is seen through the filter, "Big profits?" A really great medicine would be a new antibiotic that would save us from the mercies of MRSA. But, "Hey," they say, "Low profits that way."
So Endpoints is doing its part:
 |
| This is a bucks biz, buddy! |
Endpoints: "Over the past year we’ve seen the China biotech scene boom with billions of dollars in new investment cash pouring into a host of startups. Most of these new-breed companies are turning first to filling the tech gap that separates China from the West, but you can already see pipelines surging with new drugs that will be aimed at a world market."
None of that "Aimed at world health," dontcha see.
Comments